Trial intelligence / Profile preview

Pergolide for Cocaine Dependence

NCT00000248Phase 3Completed

Sponsor
Medical University of South Carolina
Start
Feb 1996
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pergolide in cocaine dependence (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Side effects, Drug use and 4 more. Started Feb 1996; status: completed.

02

Drugs

pergolide
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00000248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call